Summary:
We describe here a patient who died of progressive CNS deterioration following allogeneic stem cell transplant with West Nile virus as the sole pathogen on the cerebrospinal fluid and brain tissue analysis. A 50-year-old male with Philadelphia chromosome-positive acute lymphocytic leukemia (ALL) underwent allogeneic PBSCT from his HLA identical sister. After engraftment, the patient developed fever with progressive and ultimately fatal neurological deterioration. Imaging studies of the brain including CT and MRI scans were remarkable for mild low attenuation lesions of the white matter. CSF analysis was negative for neoplastic cells, bacteria, AFB, CMV, HSV, fungal infections and leukemic relapse. However, serological analysis of both the serum and CSF was positive for West Nile virus-specific IgM antibodies. At autopsy, West Nile virus PCR and cultures were positive in the mid-brain tissue. Electron micrographs showed evidence of viral particles. Given the recent increase in the spread of West Nile virus infections and the increased susceptibility of BMT patients to infectious complications, West Nile virus encephalitis should be considered in patients undergoing transplantation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Petersen LR, Marfin AA . West Nile virus: a primer for the clinician. Ann Intern Med 2002; 137: 173–179.
Johnson RT . West Nile virus in the US and abroad. Curr Clin Top Infect Dis 2002; 22: 52–60.
O'Leary DR, Nasci RS, Campbell GL, Marfin AA . From the Centers for Disease Control and Prevention West Nile Virus activity – United States, 2001. JAMA 2002; 288: 158–159, (discussion 159–160).
From the Centers for Disease Control and Prevention. Update: West Nile virus encephalitis – New York, 1999. JAMA 1999; 282: 1806–1807.
From the Centers for Disease Control and Prevention. Provisional surveillance summary of the West Nile virus epidemic – United States, January–November 2002. JAMA 2003; 289: 293–294.
Maschke M, Dietrich U, Prumbaum M et al. Opportunistic CNS infection after bone marrow transplantation. Bone Marrow Transplant 1999; 23: 1167–1176.
Julin JE, van Burik JH, Krivit W et al. Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient. Transplant Infect Dis 2002; 4: 201–206.
Gallardo D, Ferra C, Berlanga JJ et al. Neurologic complications after allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 18: 1135–1139.
Tauro S, Toh V, Osman H, Mahendra P . Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient. Bone Marrow Transplant 2000; 26: 795–796.
Larson RA, Dodge RK, Burns CP et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Blood 1995; 85: 2025–2037.
Ratanatharathorn V, Karanes C, Lum L et al. Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC). Bone Marrow Transplant 1992; 9: 49–55.
Kelley TW, Prayson RA, Ruiz AI, Isada CM, Gordon SM . The neuropathology of West Nile virus meningoencephalitis. A report of two cases and review of the literature. Am J Clin Pathol 2003; 119: 749–753.
Shieh WJ, Guarner J, Layton M et al. The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis 2000; 6: 370–372.
Sostak P, Padovan CS, Yousry TA et al. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 2003; 60: 842–848.
Padovan CS, Gerbitz A, Sostak P et al. Cerebral involvement in graft-versus-host disease after murine bone marrow transplantation. Neurology 2001; 56: 1106–1108.
Re D, Bamborschke S, Feiden W et al. Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy. Bone Marrow Transplant 1999; 23: 295–298.
Giladi M, Metzkor-Cotter E, Martin DA et al. West Nile encephalitis in Israel, 1999: the New York connection. Emerg Infect Dis 2001; 7: 659–661.
Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu NI . West Nile encephalitis epidemic in southeastern Romania. Lancet 1998; 352: 767–771.
Lundstrom JO . Mosquito-borne viruses in western Europe: a review. J Vector Ecol 1999; 24: 1–39.
Marfin AA, Petersen LR, Eidson M et al. Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis 2001; 7: 730–735.
Mostashari F, Bunning ML, Kitsutani PT et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358: 261–264.
Nedry M, Mahon CR . West Nile virus: an emerging virus in North America. Clin Lab Sci 2003; 16: 43–49.
Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ . West Nile virus. Lancet Infect Dis 2002; 2: 519–529.
Update:. Investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion – Michigan, 2002. MMWR Morb Mortal Weekly Rep 2002; 51: 879.
Iwamoto M, Jernigan DB, Guasch A et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348: 2196–2203.
Han LL, Popovici F, Alexander Jr JP et al. Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996. J Infect Dis 1999; 179: 230–233.
Roehrig JT, Nash D, Maldin B et al. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 2003; 9: 376–379.
Campbell GL, Grady LJ, Huang C et al. Laboratory testing for West Nile virus: panel discussion. Ann NY Acad Sci 2001; 951: 179–194.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reddy, P., Davenport, R., Ratanatharathorn, V. et al. West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantation. Bone Marrow Transplant 33, 109–112 (2004). https://doi.org/10.1038/sj.bmt.1704293
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704293
Keywords
This article is cited by
-
Opportunistic Infections of the Central Nervous System in the Transplant Patient
Current Neurology and Neuroscience Reports (2013)
-
West Nile Virus Infection in the Immunocompromised Patient
Current Infectious Disease Reports (2013)
-
West Nile Virus encephalopathy in an allogeneic stem cell transplant recipient: use of quantitative PCR for diagnosis and assessment of viral clearance
Bone Marrow Transplantation (2005)